Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000506499 | SCV000602442 | uncertain significance | not specified | 2016-11-02 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000765853 | SCV000897249 | uncertain significance | Usher syndrome type 2C; Febrile seizures, familial, 4 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001347959 | SCV001542243 | likely benign | not provided | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001347959 | SCV002005449 | uncertain significance | not provided | 2024-05-07 | criteria provided, single submitter | clinical testing | Identified as a single heterozygous variant in a patient also heterozygous for a 16p12.1 deletion in published literature (PMID: 30190612) but additional evidence is not available; In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 30190612) |
Institute of Human Genetics, |
RCV004817737 | SCV005069280 | uncertain significance | Optic atrophy | 2022-01-01 | criteria provided, single submitter | clinical testing |